Earnings call transcript: Origin Materials Q1 2025 reveals EPS miss, stock drops
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals several negative factors: delayed revenue expectations for 2026, extended timelines for EBITDA breakeven, and uncertainties in product qualification. Although there is a strong cash position and potential for debt financing, the market may react negatively to the revised revenue guidance and management's unclear responses in the Q&A. The absence of a new partnership announcement and the impact of tariffs further contribute to a negative sentiment. Given these factors, the stock price is likely to decline in the next two weeks.
Key Financial Performance
Revenue for 2026 $50,000,000 to $70,000,000, a decrease from previous expectations due to delays in customer product qualification.
Revenue for 2027 $150,000,000 to $210,000,000, also impacted by the deferral of commercial scale PET cap revenue generation.
Adjusted EBITDA Expected to reach run rate positive by the end of 2026, delayed due to longer customer qualification timelines.
Cash and cash equivalents $83,000,000 at the end of the quarter, indicating a strong balance sheet.
CapEx for equipment Expected to be covered by 50% to 70% debt financing, with adjustments due to current tariffs.
Operating expenses Expected to remain consistent around $11,000,000 to $12,000,000 per quarter.
Payback period for CapPortal line Less than 18 months, despite potential tariff impacts.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Product Launch: Origin is commercializing a groundbreaking PET cap solution, targeting a $65 billion market. Over 20 companies are qualifying or preparing for qualification, including six Fortune 500 companies.
Strategic Customer Agreement: A strategic customer agreement has been signed with a multibillion-dollar packaging company for large format PET closures in the ready-to-drink, wine, and spirits market.
Market Expansion: Origin expects to realize revenue of $50 million to $70 million in 2026 and $150 million to $210 million in 2027, reflecting strong demand despite qualification delays.
Operational Efficiency: Origin is diversifying its manufacturing footprint and investing in supply chain preparedness to mitigate tariff impacts and ensure production meets demand.
Production Capacity: Catformer lines are expected to achieve double to triple the original throughput, enhancing production efficiency.
Strategic Shift: Due to qualification delays, Origin anticipates a later start for commercial scale PET cap revenue generation, now expected between one to three quarters later than initially projected.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Customer Qualification Delays: Customer product qualification is taking longer than previously projected, deferring the expected start of commercial scale PET cap revenue generation by 1 to 3 quarters. This impacts anticipated revenue for 2026 ($50M-$70M) and 2027 ($150M-$210M).
Supply Chain Disruptions: Uncertainty from global manufacturing supply chain disruptions due to tariffs and protectionist trade policies. A 10% tariff on equipment imported from Europe has been factored into financial projections.
Variable Testing Requirements: Qualification processes vary significantly by customer, leading to unexpected delays. Larger customers have more rigorous testing requirements, which can cause further delays.
Economic Factors: Potential increases in tariffs could necessitate reevaluation of strategic plans and impact international shipment timing.
Cash Flow Management: The company is managing cash flow closely, with $83M in cash and equivalents, and plans to secure debt financing to cover equipment purchases and maintain a healthy cash balance.
Production Capacity: The timeline for achieving run rate positive adjusted EBITDA is now expected by the end of 2026, contingent on the completion of customer qualifications and the ramp-up of manufacturing capacity.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
PET Cap Solution Development: Origin is commercializing its PET cap solution, addressing a $65 billion market with over 20 companies qualifying or preparing for qualification.
Strategic Customer Agreement: A signed agreement with a multibillion-dollar packaging company for large format PET closures in the ready-to-drink, wine, and spirits market.
Supply Chain Preparedness: Investing in proactive inventory strategies and multi-sourcing approaches to limit disruptions.
Manufacturing Footprint Diversification: Adjusting deployment plans to minimize tariff exposure and meet demand in different regions.
Catformer Technology Development: Improvements in throughput expected to double or triple the output of initial lines.
Revenue Guidance 2026: Expected revenue of $50 million to $70 million in 2026.
Revenue Guidance 2027: Expected revenue of $150 million to $210 million in 2027.
Adjusted EBITDA Positive: Anticipated by the end of 2026 with 8-10 Catformer lines operating at scale.
Cash Position: Ended the quarter with $83 million in cash, cash equivalents, and marketable securities.
Debt Financing: Plans to secure 50-70% coverage for equipment purchases through debt financing.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Cash Position: $83,000,000 in cash, cash equivalents, and marketable securities.
Debt Financing: Origin is seeking to secure debt financing for equipment purchases, aiming for 50% to 70% coverage.
Corporate Debt: Expected to secure some level of corporate debt in the second half of 2025.
Revenue Guidance for 2026: $50,000,000 to $70,000,000.
Revenue Guidance for 2027: $150,000,000 to $210,000,000.
EBITDA Breakeven: Expected by the end of 2026 with 8 to 10 Catformer lines operating at scale.
Payback Period: Less than 18 months for the average CapPortal line.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Why is your revenue declining further? And at what level do you want Origin One?
A:OriginOne is a plant that we have continued to operate intermittently in order to both supply customers with samples or to, frankly, develop process knowledge and product knowledge internally. We’ve been pretty explicit about turning down the operating rate substantially of Origin One so that we can use cash that would otherwise be tied up in working capital associated with that asset in other ways.
Q:Are there any exact issues faced with product qualification? Have your customers indicated any concerns with the PET caps not performing as expected?
A:There are a variety of different features that are important to our customers for any given cap. Those customers don’t necessarily all test those various features the same way, which frankly was there’s more variability there than we had originally anticipated and seen.
Q:Can you give us an update on the EBITDA breakeven and the higher CapEx that you’re going to need due to the tariff environment right now?
A:Tariffs for some of our equipment that we’re shipping in from Europe is currently targeted to be about 10%. We’ve factored that into our estimates, and given updated guidance that it’s not going to have a material impact really on the ROIC of the equipment itself at this point.
Q:Can you provide any more details on your new caps that will be available in Q3 and what regions too?
A:We expect those caps to be H-ninety one caps, which we’ve already released the product spec sheet for and that we’ve announced as our initial cap. We’re not ready to release this specific region yet.
Q:Do you have an update on the sales process for the 83-acre lot in Geismar?
A:We actually have sold 35 of those 80 acres. The remaining portion remains for sale and we are optimistic that we’ll see a transaction on that in the relatively near future.
Q:Can you provide more color on the financing options you are looking at?
A:We are currently engaged with multiple equipment lenders and making good progress towards securing equipment. We’re also in the process of sourcing corporate debt to cover off the balance of whatever we’re not able to get in terms of debt coverage for the equipment.
Q:What do I have to get excited about in the future?
A:Despite the delays that we have in qualification, I think there’s a lot to be excited about. We’ve got three more cap farmers nearing completion on a rolling basis in Q2 and Q3.
Q:Review of Unclear Management Responses
A:Management appeared to avoid giving a direct answer regarding the specific reasons for revenue decline and the exact issues faced with product qualification, as well as the specific regions for the new caps.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Adhesive equipment
America afternoon
America detail
America lot
Bissell CEO
CAHPS
CEO Co
COO Materials
Chief Product
Co Founder
Founder Chief
Founder Materials
Materials Bissell
Materials Co
Officer Materials
OriginOne
Product Officer
acre
cap region
cap way
capital equity
coverage equipment
debt capital
debt coverage
design order
equipment lender
equity market
financing option
knowledge
launch
market brand
order customer
payment
preference
quarter
standard
tariff
today investor
way variability
ORGN Transcript
Origin Materials, Inc. (ORGN) Q4 2025 Earnings Call Transcript
Unknown3-27
The earnings call highlighted several negative factors, including delays in achieving EBITDA breakeven, significant impairment expenses, and lack of clear revenue guidance. The Q&A section revealed management's avoidance of direct answers about strategic reviews and market acceptance challenges. These issues, combined with the decision to cease investments in the furanics platform and delays in commercialization, suggest a negative sentiment and potential stock price decline in the short term.
Origin Materials, Inc. (ORGN) Q3 2025 Earnings Call Transcript
Unknown11-13
The earnings call reveals significant challenges: delays in manufacturing output, reduced revenue guidance, and strategic uncertainties. The Q&A highlights management's evasive responses and lack of clear timelines, further eroding confidence. Despite some positive notes on financing and partnerships, the overall sentiment is negative due to the downward revision of guidance and operational delays, which are likely to weigh heavily on the stock price in the near term.
Origin Materials, Inc. (ORGN) Q2 2025 Earnings Call Transcript
Unknown8-14
The earnings call reveals significant manufacturing delays, leading to reduced revenue guidance and postponed EBITDA breakeven, indicating operational challenges. Despite some positive aspects like strategic partnerships and product differentiation, the financial outlook is weakened. The Q&A highlights competitive advantages but also underscores risks like NASDAQ listing compliance issues. Overall, the negative financial revisions and operational setbacks outweigh the positives, suggesting a negative stock price reaction.
Origin Materials, Inc. (NASDAQ:ORGN) Q1 2025 Earnings Call Transcript
Unknown5-17
The earnings call revealed several negative indicators: customer qualification delays, supply chain disruptions, and tariff impacts, all contributing to deferred revenue expectations for 2026 and 2027. Despite a strong cash position and plans for debt financing, the uncertainty surrounding revenue timelines and lack of specific guidance on new product regions weigh negatively. The Q&A highlighted management's evasive responses, adding to investor concerns. These factors suggest a negative sentiment, likely leading to a stock price decline between -2% to -8% over the next two weeks.
ORGN Slides
ORGN Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
